Progression to Malignancy in the Polyoma Middle T Oncoprotein Mouse Breast Cancer Model Provides a Reliable Model for Human Diseases

American Journal of Pathology

Volumn 163, Issue 5, 2003, Pages 2113-2126

  Lin, Elaine Y ^a   Jones, Joan G ^a   Li, Ping ^a   Zhu, Liyin ^a   Whitney, Kathleen D ^a   Muller, William J ^b   Pollard, Jeffrey W ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA1 INTEGRIN; CYCLIN D1; ESTROGEN RECEPTOR ALPHA; ONCOPROTEIN; POLYOMA MIDDLE T ONCOPROTEIN; PROGESTERONE RECEPTOR; TUMOR MARKER; UNCLASSIFIED DRUG; VIRUS MIDDLE T ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; BREAST EPITHELIUM; BREAST HYPERPLASIA; CELL INFILTRATION; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; MALIGNANT TRANSFORMATION; METASTASIS; MOUSE; NONHUMAN; POLYOMA VIRUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH;

EID: 0142244181     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)63568-7     Document Type: Article

References (46)

1. Greenlee RT, Murray T, Bolden S, Wingo PA: Cancer statistics, 2000. CA Cancer J Clin 2000, 50:7-33
2. Lakhani SR: The transition from hyperplasia to invasive carcinoma of the breast. J Pathol 1999, 187:272-278
3. Merlino G: Regulatory imbalances in cell proliferation and cell death during oncogenesis in transgenic mice. Semin Cancer Biol 1994, 5:13-20
4. Green JE, Shibata MA, Yoshidome K, Liu ML, Jorcyk C, Anver MR, Wigginton J, Wiltrout R, Shibata E, Kaczmarczyk S, Wang W, Liu ZY, Calvo A, Couldrey C: The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma. Oncogene 2000, 19:1020-1027
5. Furth PA: SV40 rodent tumour models as paradigms of human disease: transgenic mouse models. Dev Biol Stand 1998, 94:281-287
6. Macleod KF, Jacks T: Insights into cancer from transgenic mouse models. J Pathol 1999, 187:43-60
7. Lin EY, Nguyen AV, Russell RG, Pollard JW: Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med 2001, 193:727-740
8. Guy CT, Cardiff RD, Muller WJ: Induction of mammary tumors by expression of polyomovirus middle T oncogenes: a transgenic mouse model of a metastatic disease. Mol Cell Biol 1992, 12:954-961
9. Dankort DL, Muller WJ: Signal transduction in mammary tumorigenesis: a transgenic perspective. Oncogene 2000, 19:1038-1044
10. Asch BB: Tumor viruses and endogenous retrotransposons in mammary tumorigenesis. J Mammary Gland Biol Neoplasia 1996, 1:49-60
11. Dawe CJ, Freund R, Mandel G, Ballmer-Hofer K, Talmage DA, Benjamin TL: Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles. Am J Pathol 1987, 127:243-261
12. Brison O: Gene amplification and tumor progression. Biochim Biophys Acta 1993, 1155:25-41
13. Lapidus RG, Nass SJ, Davidson NE: The loss of estrogen and progesterone receptor gene expression in human breast cancer. J Mammary Gland Biol Neoplasia 1998, 3:85-94
14. Menard S, Tagliabue E, Campiglio M, Pupa SM: Role of HER2 gene overexpression in breast carcinoma. J Cell Physiol 2000, 182:150-162
15. Bieche I, Lidereau R: Genetic alterations in breast cancer. Genes Chromosom Cancer 1995, 14:227-251
16. Bissell MJ: The organizing principle: microenvironmental influences in the normal and malignant breast. Differentiation 2002, 70:537-546
17. Nguyen AV, Pollard JW: Colony stimulating factor-1 is required to recruit macrophages into the mammary gland to facilitate mammary ductal outgrowth. Dev Biol 2002, 247:11-25
18. Tong W, Pollard JW: Progesterone inhibits estrogen-induced cyclin D1 and cdk4 nuclear translocation, cyclin E, A-cdk2 kinase activation and cell proliferation in uterine epithelial cells in mice. Mol Cell Biol 1999, 19:2252-2264
19. Gouon-Evans V, Rothenberg ME, Pollard JW: Postnatal mammary gland development requires macrophages and eosinophils. Development 2000, 127:2269-2282
20. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Laboratory Press, 1989
21. Cardiff RD, Anver MR, Gusterson BA, Hennighausen L, Jensen RA, Merino MJ, Rehm S, Russo J, Tavassoli FA, Wakefield LM, Ward JM, Green JE: The mammary pathology of genetically engineered mice: the consensus report and recommendations from the Annapolis meeting. Oncogene 2000, 19:968-988
22. Richert MM, Schwertfeger KL, Ryder JW, Anderson SM: An atlas of mouse mammary gland development. J Mammary Gland Biol Neoplasia 2000, 5:227-241
23. Howard BA, Gusterson BA: Human breast development. J Mammary Gland Biol Neoplasia 2000, 5:119-137
24. Mallon E, Osin P, Nasiri N, Blain I, Howard B, Gusterson B: The basic pathology of human breast cancer. J Mammary Gland Biol Neoplasia 2000, 5:139-163
25. Gouon V, Lin EY, Pollard JW: Requirement of macrophages and eosinophils and their cytokines/chemokines for mammary gland development. Breast Cancer Res 2002, 4:155-164
26. Neville MC, McFadden TB, Forsyth I: Hormonal regulation of mammary differentiation and milk secretion. J Mammary Gland Biol Neoplasia 2002, 7:49-66
27. Shyamala G: Progesterone signaling and mammary gland morphogenesis. J Mammary Gland Biol Neoplasia 1999, 4:89-104
28. Roskelley CD, Bissell MJ: The dominance of the microenvironment in breast and ovarian cancer. Semin Cancer Biol 2002, 12:97-104
29. Blackshear PE: Genetically engineered rodent models of mammary gland carcinogenesis: an overview. Toxicol Pathol 2001, 29:105-116
30. Black MM, Barclay TH, Cutler SJ, Hankey BF, Asire AJ: Association of atypical characteristics of benign breast lesions with subsequent risk of breast cancer. Cancer 1972, 29:338-343
31. Dupont WD, Page DL: Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985, 312:146-151
32. Betsill Jr WL, Rosen PP, Lieberman PH, Robbins GF: Intraductal carcinoma. Long-term follow-up after treatment by biopsy alone. JAMA 1978, 239:1863-1867
33. Couch FJ, DeShano ML, Blackwood MA, Calzone K, Stopfer J, Campeau L, Ganguly A, Rebbeck T, Weber BL: BRCA1 mutations in women attending clinics that evaluate the risk of breast cancer. N Engl J Med 1997, 336:1409-1415
34. Xu X, Wagner K-U, Larson D, Weaver Z, Li C, Ried T, Henninghausen L, Wynshaw-Boris A, Deng C-X: Conditional mutation of Brca1 in mammary epithelial cells results in blunted ductal morphogenesis and tumour formation. Nat Genet 1999, 22:37-43
35. Buckley MF, Sweeney KJ, Hamilton JA, Sini RL, Manning DL, Nicholson RI, deFazio A, Watts CK, Musgrove EA, Sutherland RL: Expression and amplification of cyclin genes in human breast cancer. Oncogene 1993, 8:2127-2133
36. Matsui Y, Halter SA, Holt JT, Hogan BL, Coffey RJ: Development of mammary hyperplasia and neoplasia in MMTV-TGF alpha transgenic mice. Cell 1990, 61:1147-1155
37. Andres AC, Schonenberger CA, Groner B, Hennighausen L, LeMeur M, Gerlinger P: Ha-ras oncogene expression directed by a milk protein gene promoter: tissue specificity, hormonal regulation, and tumor induction in transgenic mice. Proc Natl Acad Sci USA 1987, 84:1299-1303
38. Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL, Lee DC: Inhibition of mammary gland involution is associated with transforming growth factor alpha but not c-myc-induced tumorigenesis in transgenic mice. Cancer Res 1995, 55:3915-3927
39. Tsukamoto AS, Grosschedl R, Guzman RC, Parslow T, Varmus HE: Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell 1988, 55:619-625
40. Maroulakou IG, Anver M, Garrett L, Green JE: Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene. Proc Natl Acad Sci USA 1994, 91:11236-11240
41. Russo IH, Russo J: Role of hormones in mammary cancer initiation and progression. J Mammary Gland Biol Neoplasia 1998, 3:49-61
42. Jamerson MH, Johnson MD, Dickson RB: Dual regulation of proliferation and apoptosis: c-myc in bitransgenic murine mammary tumor models. Oncogene 2000, 19:1065-1071
43. Li Y, Hively WP, Varmus HE: Use of MMTV-Wnt-1 transgenic mice for studying the genetic basis of breast cancer. Oncogene 2000, 19:1002-1009
44. Maglione JE, Moghanaki D, Young LJ, Manner CK, Ellies LG, Joseph SO, Nicholson B, Cardiff RD, MacLeod CL: Transgenic polyoma middle-T mice model premalignant mammary disease. Cancer Res 2001, 61:8298-8305
45. Sapi E, Kacinski BM: The role of CSF-1 in normal and neoplastic breast physiology. Proc Soc Exp Biol Med 1999, 220:1-8
46. Leek RD, Harris AL: Tumor-associated macrophages in breast cancer. J Mammary Gland Biol Neoplasia 2002, 7:177-189